Phentermine Hydrochloride
- Product NDC
- 50090-0653
- 11-digit product format
- 500900653
- Labeler code
- 50090
- Product ID
- 50090-0653_de2d050e-ec9e-4b7a-8716-f59cf8464507
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Phentermine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA040887
- Marketing category
- ANDA
- Marketing start
- 2012-08-15
- Substance
- PHENTERMINE HYDROCHLORIDE
- Active strength
- 37.5 mg/1
- Pharmacologic classes
- Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Phentermine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENTERMINE HYDROCHLORIDE | 37.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0K2I505OTV |
| Rxcui | 803348 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-0653-0 | 2023-02-07 | C162847 | 48780-1 | f386c649-c153-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg. Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg (phentermine hydrochloride, USP) CIV for oral use Initial U.S. Approval: 1959 |
| 50090-0653-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-c153-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg. Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg (phentermine hydrochloride, USP) CIV for oral use Initial U.S. Approval: 1959 |
| 50090-0653-2 | 2023-02-07 | C162847 | 48780-1 | f386c649-c153-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg. Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg (phentermine hydrochloride, USP) CIV for oral use Initial U.S. Approval: 1959 |
| 50090-0653-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-c153-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg. Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg (phentermine hydrochloride, USP) CIV for oral use Initial U.S. Approval: 1959 |
| 50090-0653-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-c153-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg. Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg (phentermine hydrochloride, USP) CIV for oral use Initial U.S. Approval: 1959 |
| 50090-0653-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-c153-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg safely and effectively. See full prescribing information for Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg. Phentermine Hydrochloride Tablets and Capsules, USP 37.5 mg (phentermine hydrochloride, USP) CIV for oral use Initial U.S. Approval: 1959 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-0653-0 | Phentermine Hydrochloride | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 29 |
| 50090-0653-1 | Phentermine Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | | 29 |
| 50090-0653-2 | Phentermine Hydrochloride | 28 in 1 BOTTLE | CAPSULE | 28 | | 29 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-0653 | PHENTERMINE HYDROCHLORIDE CAPSULE [A-S MEDICATION SOLUTIONS] | 27 | Current NDC, Legacy NDC, 3 package rows | 20240215_ea798229-fc2d-417c-9bc9-a3b942f0b64b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-0653-0 | 50090065300 | 1000 CAPSULE in 1 BOTTLE (50090-0653-0) | 1000 capsule | 2019-10-09 | 0000-00-00 | No | No | Current |
| 50090-0653-1 | 50090065301 | 30 CAPSULE in 1 BOTTLE (50090-0653-1) | 30 capsule | 2014-11-28 | 0000-00-00 | No | No | Current |
| 50090-0653-2 | 50090065302 | 28 CAPSULE in 1 BOTTLE (50090-0653-2) | 28 capsule | 2014-11-28 | 0000-00-00 | No | No | Current |